Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hercules Capital, Inc. Common Stock (NY: HTGC )

17.93 +0.31 (+1.76%)
Official Closing Price Updated: 6:30 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan
AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics 
Via Newswire.com
Hercules Capital Announces Upcoming Event for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Upcoming Events for the Financial Community
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports Third Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Expert Ratings for Hercules Capital
Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter: 
Via Benzinga
Phathom Pharmaceuticals Announces Placement of the Remaining $40 Million in Non-Dilutive Capital under its up to $300 Million Revenue Interest Financing Agreement
From Phathom Pharmaceuticals
Via GlobeNewswire
As Small Caps Rally, These 3 Finance High-Yielders Could Have Further Upside
In the past month with the Russell 2000 index up roughly 7%, as compared to the S&P 500 index up nearly 4.8%, it is evident that small cap stocks are leading the charge in this bear market rally. The... 
Via Benzinga
4 Analysts Have This to Say About Hercules Capital
Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Hercules Capital Announces Date for Release of Third Quarter 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch
Via Benzinga
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Increases Its Quarterly Cash Distribution to $0.36 per Share for the Third Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
Via Benzinga
The 2 Best Stocks For Even Higher Interest Rates
Even if the future is messy and it’s hard to guess what will happen, there are investment strategies that will get you through the next couple of years and beyond. Here are two stocks worth a closer... 
Via Talk Markets
Daily Stock Analysis: Hercules Capital Inc.
Hercules Capital Inc. is a small-cap asset management company operating in the financial services business sector. 
Via Talk Markets
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility... 
Via Benzinga
The 2 Best Stocks For The 2022 Recession
Let’s take a look at how this recession will affect the giant mega-cap companies that most investors follow, as well as some smaller companies operating in specific business niches. The difference will... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
  
Via Benzinga
Hercules Capital Reports Second Quarter 2022 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Earnings Preview For Hercules Capital
Hercules Capital (NYSE:HTGC) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Hercules... 
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Second Quarter 2022 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Hercules Capital
Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter: 
Via Benzinga
Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Completes Two Institutional Debt Financings, Raising a Total of $200.0 Million to Support Continued Growth
From Hercules Capital, Inc.
Via Business Wire
Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma
Via Benzinga
Hercules Capital Expands Its Credit Facilities to $720 Million to Support Strong Investment Portfolio Growth
From Hercules Capital, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.